KalVista Pharmaceuticals, Inc. (KALV)
NASDAQ: KALV · Real-Time Price · USD
9.12
+0.16 (1.73%)
Nov 21, 2024, 2:04 PM EST - Market open
KalVista Pharmaceuticals Cash Flow Statement
Financials in millions USD. Fiscal year is May - April.
Millions USD. Fiscal year is May - Apr.
TTM
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
Jul '24 Jul 31, 2024 | Apr '24 Apr 30, 2024 | Apr '23 Apr 30, 2023 | Apr '22 Apr 30, 2022 | Apr '21 Apr 30, 2021 | Apr '20 Apr 30, 2020 |
Net Income | -141.77 | -126.64 | -92.91 | -82.34 | -46.24 | -29.12 | |
Depreciation & Amortization | 0.85 | 0.82 | 0.72 | 0.56 | 0.54 | 0.51 | |
Loss (Gain) From Sale of Investments | -1.29 | -1.23 | 1.13 | 3.15 | 0.53 | -0.11 | |
Stock-Based Compensation | 21.7 | 21.92 | 9.92 | 11.09 | 7.12 | 4.45 | |
Other Operating Activities | 0.72 | 0.75 | -1.53 | 1.73 | -0.46 | 0.09 | |
Change in Accounts Payable | 5.71 | 4.32 | 1.11 | 1.69 | 0.15 | -1 | |
Change in Unearned Revenue | - | - | - | - | - | -12.69 | |
Change in Other Net Operating Assets | 11.36 | 10.85 | 6.31 | -14.01 | 8.2 | -6.95 | |
Operating Cash Flow | -102.72 | -89.23 | -75.26 | -78.13 | -30.17 | -44.82 | |
Capital Expenditures | -0.06 | -0.04 | -1.2 | -0.93 | -0.08 | -0.22 | |
Sale (Purchase) of Intangibles | -0.47 | -0.4 | - | - | - | - | |
Investment in Securities | -66.65 | -84.28 | 42.61 | 58.79 | -147.57 | 16.97 | |
Investing Cash Flow | -67.17 | -84.72 | 41.42 | 57.86 | -147.65 | 16.75 | |
Long-Term Debt Repaid | - | - | - | - | - | -0.05 | |
Net Debt Issued (Repaid) | - | - | - | - | - | -0.05 | |
Issuance of Common Stock | 100.39 | 97.59 | 57.03 | 1.58 | 212.12 | 11.64 | |
Other Financing Activities | 53.12 | 53.12 | 1.09 | - | - | - | |
Financing Cash Flow | 153.51 | 150.71 | 58.12 | 1.58 | 212.12 | 11.58 | |
Foreign Exchange Rate Adjustments | -1.18 | -1.21 | 1.24 | -1.17 | 0.51 | 0.26 | |
Net Cash Flow | -17.56 | -24.45 | 25.51 | -19.86 | 34.8 | -16.22 | |
Free Cash Flow | -102.78 | -89.27 | -76.46 | -79.07 | -30.25 | -45.04 | |
Free Cash Flow Margin | - | - | - | - | - | -354.89% | |
Free Cash Flow Per Share | -2.59 | -2.43 | -2.74 | -3.23 | -1.58 | -2.54 | |
Levered Free Cash Flow | -57.84 | -50.27 | -52.01 | -60.09 | -21.2 | -37.71 | |
Unlevered Free Cash Flow | -57.84 | -50.27 | -52.01 | -60.09 | -21.2 | -37.71 | |
Change in Net Working Capital | -17.36 | -15.22 | -7.84 | 10.42 | -7.43 | 17.11 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.